|
|
FDADocs 5/9/2008 | 0 (0) | 33 | 0 | 0 | English
FDA Executive Summary (Version 2) Prepared for the March 27, 2006, meeting of the Obstetrics & Gynecology Devices Panel P050011 Innovata plc ?? Adept Adhesion Reduction Solution (4% Icodextrin ... more>>
FDADocs 5/9/2008 | 0 (0) | 22 | 0 | 0 | English
NDA 20-717/S-019November 2005SPARLON??? (modafinil) Tablets [C-IV]Rx OnlyDESCRIPTION SPARLON (modafinil) is an orally administered agent for the treatment of Attent... ... more>>
FDADocs 5/9/2008 | 0 (0) | 65 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health ServiceDivision of Dermatologic and Dental Drug Products Office of Drug Evaluation V Center for Drug Evaluation and Research F... ... more>>
FDADocs 5/9/2008 | 0 (0) | 61 | 1 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health ServiceDivision of Dermatologic and Dental Drug Products Office of Drug Evaluation III Center for Drug Evaluation and Research... ... more>>
FDADocs 5/9/2008 | 0 (0) | 51 | 0 | 0 | English
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Office of Pharmacoepidemiology and Statistical Science Office of B... ... more>>
FDADocs 5/9/2008 | 0 (0) | 42 | 0 | 0 | English
MEMORANDUMDEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHDATE: FROM:October 19, 2005 ... ... more>>
FDADocs 5/9/2008 | 0 (0) | 60 | 0 | 0 | English
MEMORANDUMDEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHDATE: FROM:March 3, 2006 Tho... ... more>>
FDADocs 5/9/2008 | 0 (0) | 96 | 0 | 0 | English
MEMORANDUMDEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHDATE: FROM:October 12, 2005 ... ... more>>
FDADocs 5/9/2008 | 0 (0) | 20 | 0 | 0 | English
48370Federal Register / Vol. 67, No. 142 / Wednesday, July 24, 2002 / Rules and Regulationsthe purity of the compound in the imported material is shown by satisfactory analys... ... more>>
FDADocs 5/9/2008 | 0 (0) | 33 | 0 | 0 | English
Marketing of OTC Bronchodilator DrugsThere are two regulatory mechanisms in the United States under which over-thecounter (OTC) drugs may be marketed, the new drug application (N... ... more>>
FDADocs 5/9/2008 | 0 (0) | 25 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Center for Drug Evaluation and Research OFFICE DIRECTOR???S BACKGROUND MEMORANDUM Memorandu... ... more>>
FDADocs 5/9/2008 | 0 (0) | 28 | 0 | 0 | English
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Office of Pharmacoepidemiology and Statistical Science Office of B... ... more>>
FDADocs 5/9/2008 | 0 (0) | 24 | 0 | 0 | English
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Office of Pharmacoepidemiology and Statistical Science Office of B... ... more>>
FDADocs 5/9/2008 | 0 (0) | 14 | 0 | 0 | English
The National Institutes of Health???s 2000 Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults defines normal weight as a body mass index... ... more>>
FDADocs 5/9/2008 | 0 (0) | 25 | 0 | 0 | English
OrlistatPage 1 of 7DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health ServiceDivision of Pediatric Drug Development Office of Counter-Terrorism and Pediatrics Center for... ... more>>
| | | |
| results / page 15/25/50 |
Page: 5 of 33
|
5...
|
|